Kamada Ltd (KMDA) stock
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.09−0.04 (-0.49%)
Close on Nov 13, 2026Market cap $466.68MP/E –Yield –
Kamada total assets
Total assets on the balance sheet at the end of each period.
Kamada's total assets was $383.16M at Jun 30, 2026. For fiscal 2025 it was $378.71M, up 1.7% from the year before. The highest annual figure on record is $378.71M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $378.71M | +1.7% |
| FY2024 | Dec 31, 2024 | $372.26M | +4.9% |
| FY2023 | Dec 31, 2023 | $354.91M | +10.1% |
| FY2022 | Dec 31, 2022 | $322.38M | +1.2% |
| FY2021 | Dec 31, 2021 | $318.67M | +51.3% |
| FY2020 | Dec 31, 2020 | $210.67M | +21.2% |
| FY2019 | Dec 31, 2019 | $173.80M | +25.8% |
| FY2018 | Dec 31, 2018 | $138.12M | +13.1% |
| FY2017 | Dec 31, 2017 | $122.11M | +22.5% |
| FY2016 | Dec 31, 2016 | $99.70M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $383.16M | +4.1% |
| Q1 FY2026 | Mar 31, 2026 | $383.02M | +2.1% |
| Q4 FY2025 | Dec 31, 2025 | $378.71M | +1.7% |
| Q3 FY2025 | Sep 30, 2025 | $377.21M | +7.4% |
| Q2 FY2025 | Jun 30, 2025 | $368.17M | +4.9% |
| Q1 FY2025 | Mar 31, 2025 | $375.11M | +9.3% |
| Q4 FY2024 | Dec 31, 2024 | $372.26M | +4.9% |
| Q3 FY2024 | Sep 30, 2024 | $351.21M | +4.2% |
| Q2 FY2024 | Jun 30, 2024 | $351.04M | +11.7% |
| Q1 FY2024 | Mar 31, 2024 | $343.17M | +108226.8% |
| Q4 FY2023 | Dec 31, 2023 | $354.91M | +10.1% |
| Q3 FY2023 | Sep 30, 2023 | $337.06M | +105349.6% |
| Q2 FY2023 | Jun 30, 2023 | $314.39M | +3.4% |
| Q1 FY2023 | Mar 31, 2023 | $316.80K | -99.9% |
| Q4 FY2022 | Dec 31, 2022 | $322.38M | +1.2% |
| Q3 FY2022 | Sep 30, 2022 | $319.64K | -99.9% |
| Q2 FY2022 | Jun 30, 2022 | $304.14M | +40.6% |
| Q1 FY2022 | Mar 31, 2022 | $303.10M | +43.9% |
| Q4 FY2021 | Dec 31, 2021 | $318.67M | +54.4% |
| Q3 FY2021 | Sep 30, 2021 | $216.53M | +24.6% |
| Q2 FY2021 | Jun 30, 2021 | $216.35M | +56.6% |
| Q4 FY2020 | Dec 31, 2020 | $210.67M | +72.5% |
| Q3 FY2020 | Sep 30, 2020 | $206.35M | +107.0% |
| Q4 FY2019 | Dec 31, 2019 | $173.80M | – |
| Q4 FY2018 | Dec 31, 2018 | $138.12M | – |
| Q4 FY2017 | Dec 31, 2017 | $122.11M | – |
| Q4 FY2016 | Dec 31, 2016 | $99.70M | – |
See a number that looks wrong?